EXT1 and cancer: <b>Results:</b> EXT1 was identified as one of only two genes overlapping inflammation- and glycosylation-related gene sets, strongly associated with poor overall survival (OS), disease-specific survival (DSS), and progression-free survival (PFS) across cancers, particularly in PAAD and LUAD.